Information on the Target

FNB Private Equity has successfully acquired the 'Baby Food' segment (excluding infant formula) in France from Nestlé, which includes the brands NaturNes®, Babicao®, Babivanille®, and the P’tit franchises. These brands are consolidated under Azuré Holding and are produced at the Arches facility located in the Vosges region (88). With this acquisition, FNB Private Equity becomes the majority shareholder of Azuré Holding, with Antoine Forbin appointed as President.

As a key player in the baby food market, Azuré Holding operates a dedicated production site employing approximately 235 people. The facility has a capacity of 33,000 tons and achieves an annual revenue of around €100 million, holding 25% market share in France with a broad portfolio of over 140 recipes.

Industry Overview in France

The baby food industry in France is characterized by robust growth driven by rising awareness among parents about nutrition and the increasing demand for organic and natural food products for children. Recent trends indicate a shift towards healthier options, including plant-based ingredients and clean-label products that resonate with health-conscious consumers.

In France, the baby food segment is heavily influenced by regulatory standards aimed at ensuring high-quality and safe products for infants and toddlers. This regulatory landscape encourages innovation and improvements among manufacturers seeking to comply with strict health requirements, thereby fostering competition within the market.

Moreover, the market is witnessing a surge in e-commerce sales, especially post-pandemic, as more parents opt for online shopping to ease access to diverse baby food options. Companies are increasingly focusing on digital marketing strategies to engage consumers effectively and boost brand visibility.

As a result, the competitive landscape is becoming more dynamic, with both established players and new entrants striving to capture market share. Innovations in packaging, product development, and strategic partnerships are key factors driving growth in this sector.

The Rationale Behind the Deal

This acquisition aligns with FNB Private Equity's growth and innovation strategy for the NaturNes®, Babicao®, Babivanille®, and P’tit brands. By leveraging the operational excellence and environmental performance of the Arches facility, FNB aims to enhance product offerings while maintaining focus on their values of naturalness and transparency. The deal also reflects FNB's commitment to supporting brands with high development potential within a unique market position.

Information about the Investor

FNB Private Equity is known for being a significant investor in middle-market companies that transform and market food products. As a 'mission-driven' company since 2022 and a signatory of the Principles for Responsible Investment (PRI) since 2017, FNB emphasizes social responsibility and sustainable practices in its investment strategies.

With extensive expertise in the food supply chain and operational improvements, FNB Private Equity equips its portfolio companies with the necessary resources to pursue future growth. Their team is comprised of former industry executives experienced in handling transitions and carve-outs, ensuring a hands-on approach towards enhancing operational efficiencies and market positioning.

View of Dealert

This acquisition presents a strong investment opportunity by positioning FNB Private Equity at the forefront of the growing baby food market in France. The existing market trends favor brands that prioritize natural ingredients and transparency, aligning perfectly with the values of the acquired brands.

Furthermore, the operational capabilities of the Arches facility combined with the extensive experience of Antoine Forbin in the infant care sector suggest a strategic roadmap rich in potential. With the right focus on innovation and consumer engagement, there is significant scope for market expansion and increased brand loyalty.

FNB’s commitment to maintaining existing social and employment ties alongside fostering innovation will likely enhance brand reputation and market presence, thus creating a robust platform for sustainable growth.

Overall, this acquisition by FNB Private Equity could represent a well-calibrated investment that leverages industry trends while maximizing the unique strengths of the acquired brand portfolio.

View Original Article

Similar Deals

Antony and Bernard Cohen-Skalli Pastacorp

2025

Management Buyout (MBO) Food & Drug Retailing France
FrenchFood Capital SOPANO

2025

Management Buyout (MBO) Food & Drug Retailing France
Dentressangle Naturacare et Dietopack

2023

Management Buyout (MBO) Food & Drug Retailing France
FNB Private Equity Mousline SAS

2023

Management Buyout (MBO) Food & Drug Retailing France
OLMA Luxury Holdings Caviar House & Prunier Group

2023

Management Buyout (MBO) Food & Drug Retailing France
Bluegem Nutrimuscle group

2022

Management Buyout (MBO) Food & Drug Retailing France
Eric Levet ROLMER

2021

Management Buyout (MBO) Food & Drug Retailing France
Thierry Goubault Charles & Alice

2021

Management Buyout (MBO) Food & Drug Retailing France
Mérieux Equity Partners Plantex Group

2020

Management Buyout (MBO) Food & Drug Retailing France
IK Investment Partners Mademoiselle Desserts

2018

Management Buyout (MBO) Food & Drug Retailing France

FNB Private Equity

invested in

Azuré holding

in 2024

in a Management Buyout (MBO) deal

Disclosed details

Revenue: $100M

Deal Parametres
Industry
Country
Seller type

Sign Up to Dealert